Latest news with #Asian market
Yahoo
2 days ago
- Business
- Yahoo
Asian Market Highlights: Penny Stocks To Watch In August 2025
As global markets navigate a landscape marked by shifting trade policies and monetary adjustments, the Asian market continues to capture attention with its diverse economic activities and robust stock performances. Amidst this backdrop, penny stocks—though an older term—remain a focal point for investors seeking potential growth in smaller or newer companies. By identifying those with strong financial health, investors can uncover opportunities that balance risk with promising returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.30 THB4.25B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$2.86 HK$2.33B ★★★★★★ Lever Style (SEHK:1346) HK$1.48 HK$915.41M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.52 HK$2.1B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.68 SGD648.3M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.88 SGD11.33B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.95 THB1.4B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.82 THB9.74B ★★★★★★ BRC Asia (SGX:BEC) SGD3.55 SGD973.94M ★★★★★★ Click here to see the full list of 977 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. K. Wah International Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: K. Wah International Holdings Limited is an investment holding company involved in property development and investment in Hong Kong and Mainland China, with a market capitalization of approximately HK$7.79 billion. Operations: The company's revenue is primarily derived from property development in Mainland China (HK$5.91 billion) and Hong Kong (HK$540.49 million), along with property investment generating HK$642.97 million. Market Cap: HK$7.79B K. Wah International Holdings, with a market capitalization of HK$7.79 billion, derives substantial revenue from property development in Mainland China and Hong Kong. It has managed to reduce its debt-to-equity ratio over the past five years, maintaining a satisfactory net debt level relative to equity. The company's short-term assets significantly exceed both its short- and long-term liabilities, reflecting strong liquidity. However, recent earnings have declined sharply by 58.2%, with forecasts indicating further declines over the next three years. Despite trading below estimated fair value, its return on equity remains low at 0.9%, and dividend stability is uncertain due to an unstable track record. Click here and access our complete financial health analysis report to understand the dynamics of K. Wah International Holdings. Learn about K. Wah International Holdings' future growth trajectory here. China Shanshui Cement Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Shanshui Cement Group Limited is an investment holding company that manufactures and sells cement, clinker, concrete, and related products and services in the People's Republic of China, with a market cap of HK$3.83 billion. Operations: The company generates CN¥13.50 billion in revenue from its operations in manufacturing and trading cement, clinker, and concrete. Market Cap: HK$3.83B China Shanshui Cement Group has seen a volatile share price recently, reflecting broader challenges in the sector. Despite becoming profitable last year, its earnings have been impacted by large one-off items and declining sales, with recent half-year revenue at CN¥5.55 billion compared to CN¥6.57 billion previously. The company reported a net loss of CN¥250 million for the same period but has improved from a larger loss last year. Its debt management is prudent with a satisfactory net debt to equity ratio of 13.2%, though short-term liabilities exceed assets, posing potential liquidity concerns amidst ongoing legal issues and governance changes. Click here to discover the nuances of China Shanshui Cement Group with our detailed analytical financial health report. Explore historical data to track China Shanshui Cement Group's performance over time in our past results report. Fuan Pharmaceutical (Group) Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Fuan Pharmaceutical (Group) Co., Ltd. is engaged in the research, development, production, and sale of chemical drugs in China with a market cap of CN¥5.85 billion. Operations: The company generates CN¥2.05 billion in revenue from its pharmaceutical industry segment. Market Cap: CN¥5.85B Fuan Pharmaceutical (Group) Co., Ltd. offers a stable investment profile within the penny stock segment, with its CN¥2.05 billion revenue from pharmaceuticals and a market cap of CN¥5.85 billion. The company boasts seasoned management and board teams, with average tenures of 14.3 and 3.7 years respectively, supporting strategic continuity. Short-term assets comfortably cover both short- and long-term liabilities, while operating cash flow adequately covers debt obligations at 20%. Despite negative earnings growth last year, profit margins improved to 11% from 9.7%, indicating operational resilience amid challenges in the broader pharmaceutical industry landscape. Navigate through the intricacies of Fuan Pharmaceutical (Group) with our comprehensive balance sheet health report here. Gain insights into Fuan Pharmaceutical (Group)'s past trends and performance with our report on the company's historical track record. Seize The Opportunity Click through to start exploring the rest of the 974 Asian Penny Stocks now. Interested In Other Possibilities? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:173 SEHK:691 and SZSE:300194. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
2 days ago
- Business
- Yahoo
Asian Market Highlights: Penny Stocks To Watch In August 2025
As global markets navigate a landscape marked by shifting trade policies and monetary adjustments, the Asian market continues to capture attention with its diverse economic activities and robust stock performances. Amidst this backdrop, penny stocks—though an older term—remain a focal point for investors seeking potential growth in smaller or newer companies. By identifying those with strong financial health, investors can uncover opportunities that balance risk with promising returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.30 THB4.25B ★★★★★☆ JBM (Healthcare) (SEHK:2161) HK$2.86 HK$2.33B ★★★★★★ Lever Style (SEHK:1346) HK$1.48 HK$915.41M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.52 HK$2.1B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.68 SGD648.3M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.88 SGD11.33B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.95 THB1.4B ★★★★★★ Livestock Improvement (NZSE:LIC) NZ$0.95 NZ$135.23M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.82 THB9.74B ★★★★★★ BRC Asia (SGX:BEC) SGD3.55 SGD973.94M ★★★★★★ Click here to see the full list of 977 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. K. Wah International Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: K. Wah International Holdings Limited is an investment holding company involved in property development and investment in Hong Kong and Mainland China, with a market capitalization of approximately HK$7.79 billion. Operations: The company's revenue is primarily derived from property development in Mainland China (HK$5.91 billion) and Hong Kong (HK$540.49 million), along with property investment generating HK$642.97 million. Market Cap: HK$7.79B K. Wah International Holdings, with a market capitalization of HK$7.79 billion, derives substantial revenue from property development in Mainland China and Hong Kong. It has managed to reduce its debt-to-equity ratio over the past five years, maintaining a satisfactory net debt level relative to equity. The company's short-term assets significantly exceed both its short- and long-term liabilities, reflecting strong liquidity. However, recent earnings have declined sharply by 58.2%, with forecasts indicating further declines over the next three years. Despite trading below estimated fair value, its return on equity remains low at 0.9%, and dividend stability is uncertain due to an unstable track record. Click here and access our complete financial health analysis report to understand the dynamics of K. Wah International Holdings. Learn about K. Wah International Holdings' future growth trajectory here. China Shanshui Cement Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: China Shanshui Cement Group Limited is an investment holding company that manufactures and sells cement, clinker, concrete, and related products and services in the People's Republic of China, with a market cap of HK$3.83 billion. Operations: The company generates CN¥13.50 billion in revenue from its operations in manufacturing and trading cement, clinker, and concrete. Market Cap: HK$3.83B China Shanshui Cement Group has seen a volatile share price recently, reflecting broader challenges in the sector. Despite becoming profitable last year, its earnings have been impacted by large one-off items and declining sales, with recent half-year revenue at CN¥5.55 billion compared to CN¥6.57 billion previously. The company reported a net loss of CN¥250 million for the same period but has improved from a larger loss last year. Its debt management is prudent with a satisfactory net debt to equity ratio of 13.2%, though short-term liabilities exceed assets, posing potential liquidity concerns amidst ongoing legal issues and governance changes. Click here to discover the nuances of China Shanshui Cement Group with our detailed analytical financial health report. Explore historical data to track China Shanshui Cement Group's performance over time in our past results report. Fuan Pharmaceutical (Group) Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Fuan Pharmaceutical (Group) Co., Ltd. is engaged in the research, development, production, and sale of chemical drugs in China with a market cap of CN¥5.85 billion. Operations: The company generates CN¥2.05 billion in revenue from its pharmaceutical industry segment. Market Cap: CN¥5.85B Fuan Pharmaceutical (Group) Co., Ltd. offers a stable investment profile within the penny stock segment, with its CN¥2.05 billion revenue from pharmaceuticals and a market cap of CN¥5.85 billion. The company boasts seasoned management and board teams, with average tenures of 14.3 and 3.7 years respectively, supporting strategic continuity. Short-term assets comfortably cover both short- and long-term liabilities, while operating cash flow adequately covers debt obligations at 20%. Despite negative earnings growth last year, profit margins improved to 11% from 9.7%, indicating operational resilience amid challenges in the broader pharmaceutical industry landscape. Navigate through the intricacies of Fuan Pharmaceutical (Group) with our comprehensive balance sheet health report here. Gain insights into Fuan Pharmaceutical (Group)'s past trends and performance with our report on the company's historical track record. Seize The Opportunity Click through to start exploring the rest of the 974 Asian Penny Stocks now. Interested In Other Possibilities? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:173 SEHK:691 and SZSE:300194. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
TechCrunch
30-07-2025
- Business
- TechCrunch
Google proposes to open Play Store to more real-money games in India
Google has proposed sweeping changes to its Play Store and advertising policies in India, aiming to allow more real-money gaming apps onto its platforms in a bid to settle an ongoing antitrust case with a local online gaming platform WinZO. On Wednesday, India's competition watchdog issued a public notice (PDF) inviting comments on a 'commitment proposal' from Google, offering to expand access to its Play Store and advertising policy for more real-money gaming apps in the South Asian market. Google proposed to replace its current pilot program by allowing the distribution of all real-money games in the country, which are 'self-declared by developers as permissible online real-money games as per applicable laws/jurisprudence' on Google Play in the country. However the developers are also required to submit proof that an authoritative third-party body has declared the app to be a 'game of skill,' the company proposed. In September 2022, Google launched a pilot program to allow daily fantasy sports and rummy games on its Play Store in India. The move came after a 2021 ruling by India's Supreme Court that categorized fantasy sports as 'games of skill' rather than gambling — and therefore 'legal.' Shortly after the pilot launched, online gaming platform WinZO filed a complaint with India's antitrust watchdog, calling the program discriminatory for excluding other real-money games. The Competition Commission of India (CCI) took up the case and, in November that year, ordered a formal probe into Google's policies for real-money gaming apps. In January last year, Google announced it would expand support for real-money gaming apps on the Play Store in India, Brazil, and Mexico. However, the company paused that rollout in June and stated it would continue to allow apps already included in the 2022 India pilot to remain on the platform. Techcrunch event Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. Tech and VC heavyweights join the Disrupt 2025 agenda Netflix, ElevenLabs, Wayve, Sequoia Capital — just a few of the heavy hitters joining the Disrupt 2025 agenda. They're here to deliver the insights that fuel startup growth and sharpen your edge. Don't miss the 20th anniversary of TechCrunch Disrupt, and a chance to learn from the top voices in tech — grab your ticket now and save up to $675 before prices rise. San Francisco | REGISTER NOW Alongside offering to expand its Play Store for all real-money games self-declared by developers, Google proposed to update its Developer Program Policies to reflect the update. The company also stated that it would finalize an 'appropriate business model' for real-money game developers. Similarly, Google has proposed to allow 'games of skill' to be advertised in India where the app maker provides proof by a third-party that it is a game of skill and not gambling. The recognized third parties in this case could even be industry associations such as the All India Gaming Federation, E-Gaming Federation, or the Federation of Indian Fantasy Sports. Google said it would begin allowing compliant real-money games on its Play Store in India within 120 days of the CCI's approval, while related ad policy changes would take effect within 150 days of the regulator's order. 'We're pleased the CCI is market testing our proposed framework for real-money games (RMGs) in India,' a Google spokesperson said in a statement emailed to TechCrunch. 'This development reflects our constructive discussions with the CCI and the Indian developer community along with our commitment to building a more open and safe ecosystem for RMG apps across Google Play and Google Ads.' Notably, the proposal, if it is accepted by the CCI after public feedback, would benefit Google, which stands to earn a share of revenue from a broader range of real-money gaming apps and their ads on its platforms. Real-money gaming dominates India's online gaming market, accounting for nearly 86% of total industry revenue — ₹274.38 billion ($3 billion) in 2024 — per a joint report by WinZO and the Interactive Entertainment and Innovation Council (IEIC) released earlier this year. However, its share is expected to decline slightly to 80% by 2029, as non-real-money games grow in popularity and the overall market expands to ₹785.51 billion ($8.9 billion). Google's latest proposal could also offer a boost to developers currently distributing their apps outside the Play Store — including via APK files on their own websites. However, the CCI's investigation is still ongoing, and the regulator has yet to determine whether Google engaged in discriminatory practices in this space. The probe adds to a growing list of antitrust challenges for Google in India, where the U.S.-headquartered tech giant has already been fined for allegedly abusing its dominance through Android and the Play Store. The company recently approached the Supreme Court to appeal one of these rulings and contest the CCI's findings. The case is expected to be listed for hearing next month. 'We look forward to continuing to work with the CCI and the wider RMG ecosystem, and are confident our proposed framework will empower Indian developers, grow the digital economy, and prioritize user safety,' Google's spokesperson said.
